Inhibikase Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Apr 15 16:14 ET
Inhibikase Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Werner Milton H.
Apr 3 16:51 ET
Inhibikase Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Lees-Rolfe Garth
Apr 2 17:17 ET
Inhibikase Therapeutics | 8-K/A: Current report (Amendment)
Apr 2 17:17 ET
Inhibikase Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Lees-Rolfe Garth
Apr 2 17:17 ET
Inhibikase Therapeutics | 10-K: Annual report
Mar 27 16:12 ET
Inhibikase Therapeutics | 8-K: Current report
Feb 7 08:01 ET
Inhibikase Therapeutics | 424B5: Prospectus
Feb 1 16:54 ET
Inhibikase Therapeutics | 8-K: Current report
Feb 1 16:14 ET
Inhibikase Therapeutics | 8-K: Current report
Jan 16 00:00 ET
Inhibikase Therapeutics: Q3 2023 Earnings Report
Nov 14, 2023 16:15 ET
Inhibikase Therapeutics | 10-K/A: Annual report (Amendment)
Oct 16, 2023 17:24 ET
Inhibikase Therapeutics | 8-K: Current report
Sep 20, 2023 11:23 ET
Inhibikase Therapeutics | 10-Q: Q2 2023 Earnings Report
Aug 14, 2023 16:07 ET
Inhibikase Therapeutics | 8-K: Current report
Jul 17, 2023 17:29 ET
Inhibikase Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director BERMAN DENNIS N
Jul 5, 2023 21:18 ET
Inhibikase Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Dion Gisele
Jul 5, 2023 21:16 ET
Inhibikase Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director GRINT PAUL C
Jul 5, 2023 21:12 ET
Inhibikase Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Freeman Roy Lester
Jul 5, 2023 21:11 ET
Inhibikase Therapeutics | 8-K: Current report
Jun 29, 2023 12:15 ET
No Data
No Data